Showing results (71-80 of 137) with videos related to
Sort By:
Pageof 14
Multiple Sclerosis (Houndmills, Basingstoke, England)|May 6, 2026
Kappa free light chain index or oligoclonal bands testing in clinical practice for multiple sclerosis diagnosis: An algorithm comparative studyMichaël Levraut, Mikael Cohen, Delphine Sterlin, et al.Multiple Sclerosis (Houndmills, Basingstoke, England)|January 3, 2024
Control of disease activity with large extended-interval dosing of rituximab/ocrelizumab in highly active pediatric multiple sclerosisMelany Venet, Anne Lepine, Adil Maarouf, et al.Multiple Sclerosis (Houndmills, Basingstoke, England)|December 1, 2022
Pregnancy and post-partum in patients with myelin-oligodendrocyte glycoprotein antibody-associated diseaseClarisse Carra-Dallière, Fabien Rollot, Romain Deschamps, et al.Multiple Sclerosis and Related Disorders|August 5, 2021
MSCopilot: New smartphone-based digital biomarkers correlate with Expanded Disability Status Scale scores in people with Multiple SclerosisIan-Christopher Tanoh, Elisabeth Maillart, Pierre Labauge, et al.Multiple Sclerosis and Related Disorders|May 30, 2025
Genetic diseases misdiagnosed as multiple sclerosis: Observational study and review of literatureDaniele Mandia, Natalia Shor, Alise K Carlson, et al.Neurology(R) Neuroimmunology & Neuroinflammation|June 16, 2017
Natalizumab-PML survivors with subsequent MS treatment: Clinico-radiologic outcomeElisabeth Maillart, Jean-Sebastien Vidal, David Brassat, et al.European Journal of Neurology|October 26, 2020
Outcomes of coronavirus disease 2019 in patients with neuromyelitis optica and associated disordersCéline Louapre, Elisabeth Maillart, Caroline Papeix, et al.Journal of Neuroradiology = Journal De Neuroradiologie|December 3, 2024
MRI management of NMOSD and MOGAD: Proposals from the French Expert Group NOMADMUSFrançoise Durand-Dubief, Natalia Shor, Bertrand Audoin, et al.European Journal of Neurology|February 2, 2021
The long-term outcome of MOGAD: An observational national cohort study of 61 patientsRomain Deschamps, Julie Pique, Xavier Ayrignac, et al.Multiple Sclerosis (Houndmills, Basingstoke, England)|May 4, 2018
Efficacy of rituximab in refractory RRMSPierre Durozard, Adil Maarouf, Clémence Boutiere, et al.Pageof 14